Public Health Value of a Hypothetical Pneumococcal Conjugate Vaccine (PCV) Introduction: A Case Study

Background: Understanding the public health value of a vaccine at an early stage of development helps in valuing and prioritizing the investment needed. Here we present the potential cost-effectiveness of an upcoming 12 valent pneumococcal conjugate vaccine (PCV 12) in the case study country, Thaila...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaiyakunapruk, Nathorn, Song, Dayoung, Lynch, Julia, Kim, Jerome H., Dilokthornsakul, Piyameth, Chotpitayasunondh, Tawee, Mogasale, Vittal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227762/
https://www.ncbi.nlm.nih.gov/pubmed/35746558
http://dx.doi.org/10.3390/vaccines10060950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227762/
https://www.ncbi.nlm.nih.gov/pubmed/35746558
http://dx.doi.org/10.3390/vaccines10060950

Ejemplares similares